A genome-wide association study of antidepressant response in Koreans
- Authors
- Myung, W.; Kim, J.; Lim, S-W; Shim, S.; Won, H-H; Kim, Seonwoo; Kim, Sangha; Lee, M-S; Chang, H. S.; Kim, J-W; Carroll, B. J.; Kim, D. K.
- Issue Date
- 8-Sep-2015
- Publisher
- Nature Publishing Group
- Keywords
- GWAS; depression; antidepressant; treatment response; genetics
- Citation
- Translational Psychiatry, v.5
- Journal Title
- Translational Psychiatry
- Volume
- 5
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10277
- DOI
- 10.1038/tp.2015.127
- ISSN
- 2158-3188
- Abstract
- We conducted a three-stage genome-wide association study (GWAS) of response to antidepressant drugs in an ethnically homogeneous sample of Korean patients in untreated episodes of nonpsychotic unipolar depression, mostly of mature onset. Strict quality control was maintained in case selection, diagnosis, verification of adherence and outcome assessments. Analyzed cases completed 6 weeks of treatment with adequate plasma drug concentrations. The overall successful completion rate was 85.5%. Four candidate single-nucleotide polymorphisms (SNPs) on three chromosomes were identified by genome-wide search in the discovery sample of 481 patients who received one of four allowed selective serotonin reuptake inhibitor (SSRI) antidepressant drugs (Stage 1). In a focused replication study of 230 SSRI-treated patients, two of these four SNP candidates were confirmed (Stage 2). Analysis of the Stage 1 and Stage 2 samples combined (n = 711) revealed GWAS significance (P = 1.60 x 10(-8)) for these two SNP candidates, which were in perfect linkage disequilibrium. These two significant SNPs were confirmed also in a focused cross-replication study of 159 patients treated with the non-SSRI antidepressant drug mirtazapine (Stage 3). Analysis of the Stage 1, Stage 2 and Stage 3 samples combined (n = 870) also revealed GWAS significance for these two SNPs, which was sustained after controlling for gender, age, number of previous episodes, age at onset and baseline severity (P = 3.57 x 10(-8)). For each SNP, the response rate decreased (odds ratio = 0.31, 95% confidence interval: 0.20-0.47) as a function of the number of minor alleles (non-response alleles). The two SNPs significantly associated with antidepressant response are rs7785360 and rs12698828 of the AUTS2 gene, located on chromosome 7 in 7q11.22. This gene has multiple known linkages to human psychological functions and neurobehavioral disorders. Rigorous replication efforts in other ethnic populations are recommended.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Soonchunhyang Institute of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10277)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.